Piotr Kulig

Szczecin, ZP 70252, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Fibroblast-Based Cell Therapy: Molecular Background, Current Therapies and Future Perspectives.

Fibroblast-Based Cell Therapy: Molecular Background, Current Therapies and Future Perspectives.

Journal: Cells
Published: January 27, 2026

Vascular Access Devices for Stem Cell Transplantation: A Review of Catheter Types-A Crucial Step Towards the Enhancement of Patient Care.

Vascular Access Devices for Stem Cell Transplantation: A Review of Catheter Types-A Crucial Step Towards the Enhancement of Patient Care.

Journal: Cancers
Published: September 03, 2025

Epigenetic modifications of the PHOX2A and CDH2 genes expression- new insights into the pathogenesis of multiple myeloma.

Epigenetic modifications of the PHOX2A and CDH2 genes expression- new insights into the pathogenesis of multiple myeloma.

Journal: BMC cancer
Published: July 24, 2025

Impact of cryotherapy on incidence and severity of oral mucositis in hematopoietic stem cell transplantation: retrospective observational study.

Impact of cryotherapy on incidence and severity of oral mucositis in hematopoietic stem cell transplantation: retrospective observational study.

Journal: Scientific reports
Published: June 03, 2025

The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review.

The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review.

Journal: Clinical and experimental medicine
Published: January 10, 2025

The micro-RNA expression profile predicts the severity of SARS-CoV-2 infection.

The micro-RNA expression profile predicts the severity of SARS-CoV-2 infection.

Journal: Scientific reports
Published: October 23, 2024

Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cells.

Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cells.

Journal: Scientific reports
Published: April 09, 2024

Incidence of Catheter-Associated Bloodstream Infections in Stem Cell Recipients-Should We Be "PICCy"?

Incidence of Catheter-Associated Bloodstream Infections in Stem Cell Recipients-Should We Be "PICCy"?

Journal: Cancers
Published: February 06, 2024

Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib.

Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib.

Journal: Nutrients
Published: November 30, 2023

Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action.

Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action.

Journal: Cancers
Published: November 29, 2023

VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission.

VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission.

Journal: International journal of molecular sciences
Published: October 28, 2023

5-Aza-2'-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential.

5-Aza-2'-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential.

Journal: International journal of molecular sciences
Published: October 18, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026